Related Experiment Video
Updated: Aug 5, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Anticoagulant therapy in heart disease. A summary of the literature
Insights
Anticoagulant therapy significantly reduces thromboembolic complications in specific heart conditions like myocardial infarction and rheumatic heart disease. Careful administration is crucial, restricting use to clear indications and safe facilities.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Anticoagulant therapy is widely used in managing certain heart diseases.
- Established benefits include reduced thromboembolic complications, morbidity, and mortality.
Purpose of the Study:
- To review the efficacy and safety of anticoagulant use in heart disease.
- To delineate appropriate indications for anticoagulant therapy.
Main Methods:
- Review of existing clinical experience and literature on anticoagulant use.
- Analysis of outcomes in patients with myocardial infarction, rheumatic heart disease, and congestive heart failure.
Main Results:
- Anticoagulants are proven effective in acute coronary occlusion with myocardial infarction and rheumatic heart disease with atrial fibrillation.
- A reduction in thromboembolic complications is observed in congestive heart failure, though the overall benefit is less certain.
- Anticoagulant administration demands meticulous attention and monitoring.
Conclusions:
- Anticoagulant therapy is beneficial for specific cardiac conditions with clear indications.
- Use should be limited to situations where efficient and safe administration is feasible.
- Careful patient selection and monitoring are paramount for optimal outcomes.
Abstract:
Considerable experience by many independent workers with the use of anticoagulants in the treatment of certain types of heart disease has shown that such therapy reduces significantly the incidence of thromboembolic complications and, largely through this effect, the morbidity and mortality rate from heart disease of these types. This is certainly established in acute coronary occlusion with myocardial infarction and in those instances of rheumatic heart disease with auricular fibrillation in which repeated embolic phenomena have occurred. The case for the administration of the anticoagulants in congestive heart failure is less secure, although there is no doubt that the number of thromboembolic complications is reduced by use of them. The administration of the anticoagulants requires considerably more exacting attention than does the administration of the majority of therapeutic agents in use commonly today. Hence, it is suggested that the use of anticoagulants in heart disease be restricted to those instances in which the indications are clear and facilities are compatible with the efficient and safe use of the drug, whether Dicumarol or heparin.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Venous Thrombosis III: Interprofessional Care